ARCHIVES

Amgen, J&J Defend ESA Indications.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of February

February 22, 2013

NIH Electronic Grant Coding System Worse Than NCI’s Manual Method, Advocates Say.

September 5, 2008

What Research Will, Will Not Be Funded At Various Levels – FY 1997 ZBB

October 14, 1977

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

ACS names new officers.

December 5, 2003

Solomon Garb’s Questions/Answers

December 19, 1980